Novel Macrocyclic Antagonists of the CGRP Receptor Part 2: Stereochemical Inversion Induces an Unprecedented Binding Mode.
Southall, S.M., Banerjee, J., Brown, J., Butkovic, K., Cansfield, A.D., Cansfield, J.E., Congreve, M.S., Cseke, G., Deflorian, F., Hunjadi, M.P., Hutinec, A., Inturi, T.K., Rupcic, R., Saxty, G., Watson, S.P.(2022) ACS Med Chem Lett 13: 1776-1782
- PubMed: 36385934 
- DOI: https://doi.org/10.1021/acsmedchemlett.2c00400
- Primary Citation of Related Structures:  
8AX5, 8AX6, 8AX7 - PubMed Abstract: 
The diastereomeric macrocyclic calcitonin gene-related peptide (CGRP) antagonists HTL0029881 ( 3 ) and HTL0029882 ( 4 ), in which the stereochemistry of a spiro center is reversed, surprisingly demonstrate comparable potency. X-ray crystallographic characterization demonstrates that 3 binds to the CGRP receptor in a precedented manner but that 4 binds in an unprecedented, unexpected, and radically different manner. The observation of this phenomenon is noteworthy and may open novel avenues for CGRP receptor antagonist design.
Organizational Affiliation: 
Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, United Kingdom.